Fenaux, Pierre Giagounidis, Aristoteles Selleslag, Dominik Beyne-Rauzy, Odile Mittelman, Moshe Muus, Petra Nimer, Stephen HellstrÜm-Lindberg, Eva Powell, Bayard Guerci-Bresler, Agnes Sekeres, Mikkael Deeg, H. del Caùizo, Consuelo Greenberg, Peter Shammo, Jamile Skikne, Barry Yu, Xujie List, Alan Additional file 1: Figure S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q) Study populations in the MDS-003 and MDS-004 studies. Gray shaded boxes: age groups in the present analysis. LEN, lenalidomide. (DOCX 39 kb) Acute myeloid leukemia;del(5q);Lenalidomide;Myelodysplastic syndromes;Age 2017-06-26
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Figure_S1_of_Clinical_characteristics_and_outcomes_according_to_age_in_lenalidomide-treated_patients_with_RBC_transfusion-dependent_lower-risk_MDS_and_del_5q_/5146612
10.6084/m9.figshare.c.3811405_D1.v1